(Phe1Ψ(CH2-NH)Gly2)Nociceptin(1-13)NH2
(Phe1Ψ(CH2-NH)Gly2)Nociceptin(1-13)NH2 is a synthetic peptide analog of the endogenous neuropeptide nociceptin, also known as orphanin FQ. This compound is of significant interest in the field of neuroscience and pharmacology due to its potential role in modulating pain and other physiological processes.
Structure and Synthesis[edit]
(Phe1Ψ(CH2-NH)Gly2)Nociceptin(1-13)NH2 is a modified peptide based on the nociceptin sequence. The modification involves a pseudopeptide bond between the first phenylalanine (Phe) and the second glycine (Gly) residue, where the typical peptide bond is replaced by a methyleneamino linkage (CH2-NH). This alteration is designed to enhance the stability of the peptide against enzymatic degradation, potentially increasing its bioavailability and duration of action.
Mechanism of Action[edit]
Nociceptin acts as a ligand for the nociceptin receptor (NOP receptor), which is a member of the opioid receptor family. However, unlike classical opioid receptors, the NOP receptor does not bind traditional opioids such as morphine. (Phe1Ψ(CH2-NH)Gly2)Nociceptin(1-13)NH2 is believed to act as an agonist at the NOP receptor, mimicking the effects of natural nociceptin.
Pharmacological Effects[edit]
Research suggests that (Phe1Ψ(CH2-NH)Gly2)Nociceptin(1-13)NH2 may have analgesic properties, potentially offering pain relief without the addictive side effects associated with traditional opioids. Additionally, it may influence other physiological processes such as mood regulation, stress response, and appetite control.
Research and Clinical Implications[edit]
The study of (Phe1Ψ(CH2-NH)Gly2)Nociceptin(1-13)NH2 is ongoing, with researchers exploring its potential therapeutic applications in conditions such as chronic pain, anxiety disorders, and substance use disorders. Its unique mechanism of action makes it a promising candidate for developing new treatments that could circumvent the limitations of current opioid therapies.
Also see[edit]
| Hormones | ||
|---|---|---|
|
| Pharmacology | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian